Religare Enterprises reported consolidated total income of ₹8,493 crore for FY26, up ~14% YoY, driven by strong performance at Care Health Insurance (GWP ₹11,417 crore, +24% YoY...
Concise cards keep the risk register scannable while preserving evidence-level context in the underlying quarter data.
Risks
R
Promoter stake in Care may not meet IRDAI requirement
Promoter shareholding in Religare is ~30.3%, but post-demerger, Care's promoter holding may fall short of the 26% regulatory requirement, raising concerns about compliance.
high · analyst_question
R
Holding company discount persists
The demerger structure may not eliminate the holding company discount, as Care remains a subsidiary of a listed entity, potentially undervaluing the stock.
medium · analyst_question
R
NBFC ramp-up execution risk
The NBFC business is still in preparation phase with no clear timeline for disbursement growth, posing execution risk.